Glucuronidation of catechols by human hepatic, gastric, and intestinal microsomal UDP-glucuronosyltransferases (UGT) and recombinant UGT1A6, UGT1A9, and UGT2B7

被引:30
|
作者
Antonio, L
Xu, J
Little, JM
Burchell, B
Magdalou, J
Radominska-Pandya, A
机构
[1] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA
[2] Univ Henri Poincare Nancy 1, CNRS, UMR 7561, Vandoeuvre Les Nancy, France
[3] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland
关键词
UDP-glucuronosyltransferase; human; catechols; liver; stomach; intestine;
D O I
10.1016/S0003-9861(02)00748-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The substrate specificity of human gastric and intestinal UDP-glucuronosyltransferases (UGTs) toward catechols was investigated and compared to that of liver UGTs. Small catechols were efficiently glucuronidated by stomach (0.8-10.2nmol/mg protein . min) and intestine (0.9-7.7 nmol/mg protein . min) with activities in a range similar to those found in liver (2.9-19 nmol/mg protein . min). Large interindividual variations were observed among the samples. Immunoblot analysis demonstrated the presence of UGT1A6 and UGT2B7 in stomach and throughout the intestine. Recombinant human UGT1A6, 1A9, and 2B7, stably expressed in mammalian cells, all effectively catalyzed catechol glucuronidation. K-m values (0.09-13.6 mM) indicated low affinity for UGTs and V-max values ranged from 0.51 to 64.0 nmol/mg protein . min. These results demonstrate for the first time glucuronidation of catechols by gastric and intestinal microsomal UGTs and three human recombinant UGT isoforms. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:251 / 261
页数:11
相关论文
共 50 条
  • [41] Glucuronidation of flavonoids by human UGT1A3, UGT1A9 and structure-activity relationships
    Xie, Shenggu
    Chen, Yakun
    Chen, Shuqing
    Zeng, Su
    DRUG METABOLISM REVIEWS, 2006, 38 : 129 - 129
  • [42] Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes
    Peterkin, Vincent C.
    Bauman, Jonathan N.
    Goosen, Theunis C.
    Menning, Lee
    Man, Michael Z.
    Paulauskis, Joseph D.
    Williams, J. Andrew
    Myrand, Scott P.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 64 (04) : 458 - 468
  • [43] Comprehensive characterization of mouse hepatic UDP-glucuronosyltransferases: Major participation of Ugt2b1 in bisphenol A glucuronidation
    Ishii, Yuji
    Yamashita, Ryohei
    Kurita, Ayumi
    Miyauchi, Yuu
    Ikushiro, Shin'ichi
    Mackenzie, Peter I.
    Tanaka, Yoshitaka
    FASEB JOURNAL, 2019, 33
  • [44] Analysis of substrate specificities and tissue expression of rat UDP-glucuronosyltransferases UGT1A7 and UGT1A8
    Webb, LJ
    Miles, KK
    Auyeung, DJ
    Kessler, FK
    Ritter, JK
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (01) : 77 - 82
  • [45] Isoform selectivity and kinetics of morphine 3-and 6-glucuronidation by human UDP-glucuronosyltransferases: Evidence for atypical glucuronidation kinetics by UGT2B7
    Stone, AN
    Mackenzie, PI
    Galetin, A
    Houston, JB
    Miners, JO
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (09) : 1086 - 1089
  • [46] Stereoselective Glucuronidation of Propafenone and Its Analogues by Human Recombinant UGT1A9
    Xie, Shenggu
    Zeng, Su
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2010, 58 (06) : 879 - 883
  • [47] Influence of synthetic and natural food dyes on activities of CYP2A6, UGT1A6, and UGT2B7
    Kuno, N
    Mizutani, T
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2005, 68 (16): : 1431 - 1444
  • [48] Human UGT2B7 catalyzes morphine glucuronidation
    Coffman, BL
    Rios, GR
    King, CD
    Tephly, TR
    DRUG METABOLISM AND DISPOSITION, 1997, 25 (01) : 1 - 4
  • [49] Effects of UGT1A3, UGT1A6, and UGT2B7 genetic polymorphisms on plasma concentration of valproic acid in south Chinese epilepsy patients
    Shen, Xiongrong
    Bi, Jingbo
    Liu, Quankun
    Ma, Zhihong
    Min, Lishan
    Xu, Limin
    Yang, Shuixin
    Chen, Yingrong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (04): : 4513 - 4522
  • [50] Hepatocyte nuclear factor 1 alpha and 4 alpha are factors involved in interindividual variability in the expression of UGT1A6 and UGT1A9 but not UGT1A1, UGT1A3 and UGT1A4 mRNA in human livers
    Aueviriyavit, Sasitorn
    Furihata, Tomomi
    Morimoto, Kaori
    Kobayashi, Kaoru
    Chiba, Kan
    DRUG METABOLISM AND PHARMACOKINETICS, 2007, 22 (05) : 391 - 398